Traditionally, the treatment of type 2 diabetes has focused on blood glucose control and the prevention of complications. In the future, these therapeutic approaches could be complemented by another, which, according to current studies, could restore beta cell function and possibly lead to remission by targeting the reduction of glucotoxicity, lipotoxicity and insulin resistance.
Autoren
- Jens Dehn
Publikation
- InFo DIABETOLOGIE & ENDOKRINOLOGIE
Related Topics
You May Also Like
- From symptom to diagnosis
Abdominal pain – internal hernias
- Artificial intelligence for COPD
A new era of personalized treatment
- Multiple sclerosis
Spirulina as adjuvant therapy? Reduction of cytokines and inflammation
- IBD and SARS-CoV-2
Vulnerable at the mercy of others
- Case Report
53-year-old female patient with palmoplantar keratoderma
- Incontinence
Fecal incontinence from the perspective of gastroenterology
- Diagnostics of respiratory viral infections
What is tested when and on whom?
- HER2-positive breast cancer